232 related articles for article (PubMed ID: 19335661)
1. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy.
Schäfer A; Wittchen HU; Backmund M; Soyka M; Gölz J; Siegert J; Schäfer M; Tretter F; Kraus MR
Addiction; 2009 Apr; 104(4):630-40. PubMed ID: 19335661
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
[TBL] [Abstract][Full Text] [Related]
3. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance.
Schulte B; Schütt S; Brack J; Isernhagen K; Deibler P; Dilg C; Verthein U; Haasen C; Reimer J
Drug Alcohol Depend; 2010 Jun; 109(1-3):248-51. PubMed ID: 20167441
[TBL] [Abstract][Full Text] [Related]
5. Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting.
Senn O; Seidenberg A; Rosemann T
Addiction; 2009 Dec; 104(12):2033-8. PubMed ID: 19922570
[TBL] [Abstract][Full Text] [Related]
6. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment].
Rothenhäusler HB; Scherr M; Putz-Bankuti C; Kapper A; Stepan A; Baranyi A; Haas-Krammer A; Haas B; Stauber R
Fortschr Neurol Psychiatr; 2009 Aug; 77(8):457-63. PubMed ID: 19676008
[TBL] [Abstract][Full Text] [Related]
8. [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project].
Niederau C; Bemba G; Kautz A
Z Gastroenterol; 2008 Jan; 46(1):22-33. PubMed ID: 18188813
[TBL] [Abstract][Full Text] [Related]
9. Exposure to opioid maintenance treatment reduces long-term mortality.
Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
[TBL] [Abstract][Full Text] [Related]
10. Quality of life among heroin users on buprenorphine versus methadone maintenance.
Ponizovsky AM; Grinshpoon A
Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
[TBL] [Abstract][Full Text] [Related]
11. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
Soyka M; Apelt SM; Lieb M; Wittchen HU
J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
[TBL] [Abstract][Full Text] [Related]
12. Necessities of interferon therapy in elderly patients with chronic hepatitis C.
Ikeda K; Arase Y; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
Am J Med; 2009 May; 122(5):479-86. PubMed ID: 19375558
[TBL] [Abstract][Full Text] [Related]
13. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany--socioeconomic aspects in hepatitis C].
Niederau C; Bemba G; Kautz A
Z Gastroenterol; 2006 Apr; 44(4):305-17. PubMed ID: 16625459
[TBL] [Abstract][Full Text] [Related]
14. Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study.
Belfiori B; Chiodera A; Ciliegi P; Tosti A; Baldelli F; Stagni G; Francisci D
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):731-2. PubMed ID: 17625449
[No Abstract] [Full Text] [Related]
15. [Prevention and treatment of hepatitis C in illicit drug users].
Sakoman S
Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
[TBL] [Abstract][Full Text] [Related]
16. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
Maremmani I; Pani PP; Pacini M; Perugi G
J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
[TBL] [Abstract][Full Text] [Related]
17. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
[TBL] [Abstract][Full Text] [Related]
19. Depression and protective factors of mental health in people with hepatitis C: a questionnaire survey.
Erim Y; Tagay S; Beckmann M; Bein S; Cicinnati V; Beckebaum S; Senf W; Schlaak JF
Int J Nurs Stud; 2010 Mar; 47(3):342-9. PubMed ID: 19766994
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients.
Wittchen HU; Apelt SM; Soyka M; Gastpar M; Backmund M; Gölz J; Kraus MR; Tretter F; Schäfer M; Siegert J; Scherbaum N; Rehm J; Bühringer G
Drug Alcohol Depend; 2008 Jun; 95(3):245-57. PubMed ID: 18337025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
